Biologics quality testing

Faster, safer, animal free.

iDTECT^® assays by PathoQuest provide a unique NGS Quality Control platform for biologics.

Accepted by Industry and Regulators.

Why PARTNER WITH PathoQuest?

At PathoQuest, we understand the critical need to develop your innovative biologics safely and rapidly in a complex biosafety testing environment. PathoQuest provides a validated Next Generation Sequencing (NGS) approach in biosafety testing, biologics characterization, and biologics release for global biopharmaceutical and emerging biologics companies.

With a proven track record in biotesting, PathoQuest offers a team of NGS Quality Control (QC) testing experts based in France and the U.S. Our expert Contract Research Organization (CRO) team is readily available to support with rapid and robust QC testing at both GMP and non-GMP levels, emphasizing our commitment to biosafety services.

Let’s work together to transform the future of biologic therapies and make a significant impact on patient lives.

Contact us

OUR UNIQUE NGS QUALITY CONTROL ASSAYS

Discover iDTECT^®platform

Our brand for industry-leading NGS bioassays

For viral safety and genetic characterization

GMP Quality Control

LEARN MORE

OUR HAPPY CUSTOMERS

“Our partnership with PathoQuest represents a significant step forward in our commitment to empower tomorrow’s therapies today. PathoQuest’s expertise in NGS technology will greatly enhance our capabilities and allow us to deliver even greater value to our clients through our comprehensive viral vector services, from process development to cGMP manufacturing for clinical and commercial supply.”

Robert Panting
General Manager
Rentschler Biopharma, ATMP

“IAVI has chosen to work with PathoQuest as the iDTECT Virome approach has permitted us to adopt next generation sequencing (NGS) for viral safety testing, replacing the traditional in vivo and in vitro testing for the release of our vaccine vectors in a safe and timely manner. We also appreciate their virology expertise in trouble-shooting and problem-solving for safety testing of our viral vectors.”

Eddy Sayeed
Executive Director, Process Development & Vaccine Manufacturing/Vaccine
IAVI

“We have been impressed by PathoQuest’s excellent service. They supported us with their NGS-based Quality Control platform, enabling us to navigate technical and regulatory hurdles to reach a key milestone. PathoQuest has been a reliable and trustworthy partner for biosafety testing.”

Jack Elands, PhD
Former Chief Executive Officer
Emergence Therapeutics AG (recently acquired by Eli Lilly)

“We chose PathoQuest NGS viral safety tests for rapid and reliable Quality Control of our therapeutic cancer vaccine in development, ensuring batch release in weeks instead of months”

Christophe Ancel, PharmD
V.P. Pharmaceutical Operations & Qualified Person
Transgene SA

“Our collaboration with PathoQuest is helping our customers overcoming the limitations of traditional QC methods. As a CDMO, using PathoQuest’s NGS assays, we can advance our customers projects safely, while ensuring timelines are met.”

Nicolas Salavin
Head of Transformation & Integration
Oxford Biomedica (CDMO)

Modalities

mAbs and Recombinant Proteins

Bacterial and mammalian produced proteins, hormones and peptides

READ MORE

Viral Vectors

Viral gene delivery, oncolytic and immunotherapy including manufacturing plasmids

READ MORE

Cell Therapies

Including gene modiﬁed, or unmodiﬁed stem cell therapies, allogeneic or autologous

READ MORE

Vaccines

Inactivated, live-attenuated, recombinant, RNA and viral vector products

READ MORE

RNA

Immunotherapies, antiviral, vaccines, RNAi and CRISPR based gene editing

READ MORE

Cultivated Meat

Engineered cells and tissues cultured in more ethical in vitro environments

READ MORE

3Rs

Next Generation Sequencing (NGS) is the ethical alternative to in vivo testing for biologics testing.

PathoQuest, in partnership with Charles River Laboratories, pioneers in demonstrating the superiority of NGS-based biosafety testing over traditional biosafety testing and biologics characterization. Our advanced biotesting services set new standards, replacing conventional methods with faster, safer, and animal-free alternatives in biologics testing.

FIND OUT MORE

3Rs

Next generation sequencing is the ethical alternative to in vivo testing for the Quality Control testing of biologics.

PathoQuest, in partnership with Charles River Laboratories, is the ﬁrst CRO to conclusively demonstrate the superiority of NGS over conventional in vivo biosafety testing and characterization.

FIND OUT MORE